Cost-effectiveness of liver transplantation in methylmalonic and propionic acidemias

Liver Transplantation

Volumn 21, Issue 9, 2015, Pages 1208-1218

  Li, Meng ^a   Dick, Andre ^b,c   Montenovo, Martin ^b   Horslen, Simon ^b,c   Hansen, Ryan ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASSISTED LIVING FACILITY; COHORT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; COST UTILITY ANALYSIS; HEALTH CARE COST; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIFE EXPECTANCY; LIVER TRANSPLANTATION; METHYLMALONIC ACIDEMIA; MORTALITY; NEWBORN; NUTRITIONAL SUPPORT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPIONIC ACIDEMIA; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; SENSITIVITY ANALYSIS; SPECIAL EDUCATION; ADVERSE EFFECTS; AMINO ACID METABOLISM, INBORN ERRORS; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DECISION TREE; ECONOMICS; MARKOV CHAIN; PROTEIN RESTRICTION; RISK FACTOR; STATISTICAL MODEL; SURVIVOR; TIME FACTOR; TREATMENT OUTCOME;

AMINO ACID METABOLISM, INBORN ERRORS; COST-BENEFIT ANALYSIS; DECISION TREES; DIET, PROTEIN-RESTRICTED; HEALTH CARE COSTS; HUMANS; INFANT, NEWBORN; LIVER TRANSPLANTATION; MARKOV CHAINS; MODELS, ECONOMIC; NUTRITIONAL SUPPORT; PROPIONIC ACIDEMIA; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; RISK FACTORS; SURVIVORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84939802699     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.24173     Document Type: Article

References (47)

1. Manoli I, Venditti CP,. Methylmalonic Acidemia. University of Washington, Seattle, WA. http://www.ncbi.nlm.nih.gov/books/NBK1231/. Accessed November 13, 2014.
2. Carrillo-Carrasco N, Venditti C,. Propionic Acidemia. http://www.ncbi.nlm.nih.gov/books/NBK92946/. Accessed November 13, 2014.
3. Camp KM, Lloyd-Puryear MA, Huntington KL,. Nutritional treatment for inborn errors of metabolism: indications, regulations, and availability of medical foods and dietary supplements using phenylketonuria as an example. Mol Genet Metab 2012; 107: 3-9.
4. Dionisi-Vici C, Deodato F, Röschinger W, Rhead W, Wilcken B,. "Classical" organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: long-term outcome and effects expanded newborn screening using tandem mass spectrometry. J Inherit Metab Dis 2006; 29: 383-389.
5. Baumgarter ER, Viardot C,. Long-term follow-up of 77 patients with isolated methylmalonic acidaemia. J Inherit Metab Dis 1995; 18: 138-142.
6. Hörster F, Baumgartner MR, Viardot C, Suormala T, Burgard P, Fowler B, et al., Long-term outcome in methylmalonic acidurias is influenced by the underlying defect (mut0, mut-, cblA, cblB). Pediatr Res 2007; 62: 225-230.
7. Hörster F, Garbade SF, Zwickler T, Aydin HI, Bodamer OA, Burlina AB, et al., Prediction of outcome in isolated methylmalonic acidurias: combined use of clinical and biochemical parameters. J Inherit Metab Dis 2009; 32: 630-639.
8. Centers for Disease Control and Prevention. United States Life Table 2008. http://www.cdc.gov/nchs/products/life-tables.htm. Accessed August 12, 2014.
9. Nicolaides P, Leonard J, Surtees R,. Neurological outcome of methylmalonic acidaemia. Arch Dis Child 1998; 78: 508-512.
10. Grünert SC, Müllerleile S, De Silva L, Barth M, Walter M, Walter K, et al., Propionic acidemia: clinical course and outcome in 55 pediatric and adolescent patients. Orphanet J Rare Dis 2013; 8: 6.
11. Rafique M,. Propionic acidaemia: demographic characteristics and complications. J Pediatr Endocrinol Metab 2013; 26: 497-501.
12. Martín-Hernández E, Lee PJ, Micciche A, Grunewald S, Lachmann RH,. Long-term needs of adult patients with organic acidaemias: outcome and prognostic factors. J Inherit Metab Dis 2009; 32: 523-533.
13. Touati G, Valayannopoulos V, Mention K, de Lonlay P, Jouvet P, Depondt E, et al., Methylmalonic and propionic acidurias: management without or with a few supplements of specific amino acid mixture. J Inherit Metab Dis 2006; 29: 288-298.
14. Cosson MA, Benoist JF, Touati G, Déchaux M, Royer N, Grandin L, et al., Long-term outcome in methylmalonic aciduria: a series of 30 French patients. Mol Genet Metab 2009; 97: 172-178.
15. Cipriano LE, Rupar CA, Zaric GS,. The cost-effectiveness of expanding newborn screening for up to 21 inherited metabolic disorders using tandem mass spectrometry: results from a decision-analytic model. Value Health 2007; 10: 83-97.
16. Deodato F, Boenzi S, Rizzo C, Abeni D, Caviglia S, Picca S, et al., Inborn errors of metabolism: an update on epidemiology and on neonatal-onset hyperammonemia. Acta Paediatr Suppl 2004; 93: 18-21.
17. Morioka D, Kasahara M, Takada Y, Corrales JP, Yoshizawa A, Sakamoto S, et al., Living donor liver transplantation for pediatric patients with inheritable metabolic disorders. Am J Transplant 2005; 5: 2754-2763.
18. Morioka D, Kasahara M, Horikawa R, Yokoyama S, Fukuda A, Nakagawa A,. Efficacy of living donor liver transplantation for patients with methylmalonic acidemia. Am J Transplant 2007; 7: 2782-2787.
19. Kayler LK, Merion RM, Lee S, Sung RS, Punch JD, Rudich SM, et al., Long-term survival after liver transplantation in children with metabolic disorders. Pediatr Transplant 2002; 6: 295-300.
20. Charbit-Henrion F, Lacaille F, McKiernan P, Girard M, de Lonlay P, Valayannopoulos V, et al., Early and late complications after liver transplantation for propionic acidemia in children: a two centers study. Am J Transplant 2015; 15: 786-791.
21. Perito ER, Rhee S, Roberts JP, Rosenthal P,. Pediatric liver transplantation for urea cycle disorders and organic acidemias: United Network for Organ Sharing Data for 2002-2012. Liver Transpl 2014; 20: 89-99.
22. McGuire BM, Rosenthal P, Brown CC, Busch AM, Calcatera SM, Claria RS, et al.,; for American Society of Transplantation. Long-term management of the liver transplant patient: recommendations for the primary care doctor. Am J Transplant 2009; 9: 1988-2003.
23. Kasahara M, Sakamoto S, Kanazawa H, Karaki C, Kakiuchi T, Shigeta T, et al., Living-donor liver transplantation for propionic acidemia. Pediatr Transplant 2012; 16: 230-234.
24. Rela M, Battula N, Madanur M, Mieli-Vergani G, Dhawan A, Champion M, et al., Auxiliary liver transplantation for propionic acidemia: A 10-year follow-up. Am J Transplant 2007; 7: 2200-2203.
25. Nagao M, Tanaka T, Morii M, Wakai S, Horikawa R, Kasahara M,. Improved neurologic prognosis for a patient with propionic acidemia who received early living donor liver transplantation. Mol Genet Metab 2013; 108: 25-29.
26. Moscovice I, Davidson G, McCaffrey D,. Substitution of formal and informal care for the community-based elderly. Med Care 1988; 26: 971-981.
27. de Baulny HO, Benoist JF, Rigal O, Touati G, Rabier D, Saudubray JM,. Methylmalonic and propionic acidaemias: management and outcome. J Inherit Metab Dis 2005; 28: 415-423.
28. Kamath BM, Olthoff KM,. Liver trasplantation in children: update 2010. Pediatr Clin North Am 2010; 57: 401-414.
29. Levitsky J, Cohen SM,. The liver transplant recipient: what you need to know for long-term care. J Fam Pract 2006; 55: 136-144.
30. Nyhan WL, Gargus JJ, Boyle K, Selby R, Koch R,. Progressive neurologic disability in methylmalonic acidemia despite transplantation of the liver. Eur J Pediatr 2002; 161: 377-379.
31. Brassier A, Boyer O, Valayannopoulos V, Ottolenghi C, Krug P, Cosson MA, et al., Renal transplantation in 4 patients with methylmalonic aciduria: a cell therapy for metabolic disease. Mol Genet Metab 2013; 110: 106-110.
32. Nagarajan S, Enns GM, Millan MT, Winter S, Sarwal MM,. Management of methylmalonic acidaemia by combined liver-kidney transplantation. J Inherit Metab Dis 2005; 28: 517-524.
33. Kasahara M, Horikawa R, Tagawa M, Uemoto S, Yokoyama S, Shibata Y, et al., Current role of liver transplantation for methylmalonic acidemia: a review of the literature. Pediatr Transplant 2006; 10: 943-947.
34. van der Hilst CS, Ijtsma AJ, Slooff MJ, Tenvergert EM,. Cost of liver transplantation: a systematic review and meta-analysis comparing the United States with other OECD countries. Med Care Res Rev 2009; 66: 3-22.
35. Åberg F, Mäklin S, Räsänen P, Roine RP, Sintonen H, Koivusalo AM, et al., Cost of a quality-adjusted life year in liver transplantation: the influence of the indication and the Model for End-Stage Liver Disease score. Liver Transpl 2011; 17: 1333-1343.
36. Gilmour SM, Sorensen LG, Anand R, Yin W, Alonso EM,; for SPLIT Research Consortium. School outcomes in children registered in the studies for pediatric liver transplant (SPLIT) consortium. Liver Transpl 2010; 16: 1041-1048.
37. Truven Health Analytics. MarketScan Research Data. https://marketscan.truvenhealth.com/marketscanportal/. Accessed October 27, 2014.
38. McGuire S,., Lino M,. Expenditures on children by families, 2013. Washington, DC: US Department of Agriculture, Center for Nutrition Policy and Promotion; 2014. Miscellaneous Publication No. 1528-2013. Adv Nutr 2015; 6: 227-228.
39. Vara R, Turner C, Mundy H, Heaton ND, Rela M, Mieli-Vergani G, et al., Liver transplantation for propionic acidemia in children. Liver Transpl 2011; 17: 661-667.
40. Neff G,. Pharmacoeconomics of hepatic encephalopathy. Pharmacotherapy 2010; 30 (part 2): 28S-32S.
41. Social Security Administration. National Average Wage Index. http://www.ssa.gov/oact/cola/AWI.html. Accessed August 13, 2014.
42. Fredericks EM, Lopez MJ, Magee JC, Shieck V, Opipari-Arrigan L,. Psychological functioning, nonadherence and health outcomes after pediatric liver transplantation. Am J Transplant 2007; 7: 1974-1983.
43. Kaller T, Boeck A, Sander K, Richterich A, Burdelski M, Ganschow R, Schulz KH,. Cognitive abilities, behavior and quality of life in children after liver transplantation. Pediatr Transplant 2010; 14: 496-503.
44. Midgley DE, Bradlee TA, Donohoe C, Kent KP, Alonso EM,. Health-related quality of life in long-term survivors of pediatric liver transplantation. Liver Transpl 2000; 6: 333-339.
45. Taylor R, Franck LS, Gibson F, Dhawan A,. A critical review of the health-related quality of life of children and adolescents after liver transplantation. Liver Transpl 2005; 11: 51-60.
46. Meyburg J, Hoffmann GF,. Liver transplantation for inborn errors of metabolism. Transplantation 2005; 80 (suppl): S135-S137.
47. Seashore MR,. Tandem spectrometry in newborn screening. Curr Opin Pediatr 1998; 10: 609-614.